Company intelligence / Profile preview

Fox Pharma

Warrington, England, United Kingdom

Ownership: Private
Employees: ~12
Development stage: Other

Overview

Fox Pharma distributes and wholesales CE-marked and CA-marked medical aesthetic products (such as Seventy Hyal 2000, REVOLAX fillers, and Vitaran polynucleotide injectables) to clinics and medical professionals in the UK and internationally; the company is not engaged in novel therapeutic clinical trials in the biotech sense

Therapeutic areas: Dermatology
Modalities: Dermal fillerSkin boosterSmall moleculeBiologic
Industry: Consumable Medical Devices

Beyond the preview

Go deeper on Fox Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fox Pharma.

Explore the full profile